Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00612508 · ClinicalTrials.gov registry record · NA
Hormonal Contraception and Vaginal Health
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00612508: Completed NA study, sponsored by Oregon Health and Science University.
NCT00612508 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00612508, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to help determine if the route by which women receive hormonal contraception causes different changes to occur in the lining of the vagina. The investigators plan to compare an oral route (taking birth control pills) with a vaginal route (using a vaginal ring).
Primary Outcome
Histologic evalation of vaginal sections was performed to measured and record the absolute thickness of the vaginal epithelium. Baseline findings were compared to biopsies after three and six cycles of treatment. Mean values were compared using T-test for paired data for baseline and 84 days, and baseline and 168 days
Interventions
- DRUG Desogen (ethinyl estradiol and desogestrel)
- DRUG NuvaRing (ethinyl estradiol and etonogestrel)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-05 |
| Phase | NA |
What the finished NCT00612508 record still lists
NCT00612508 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Desogen (ethinyl estradiol and desogestrel) is the first listed.
NCT00612508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00612508 about?
NCT00612508 is a clinical study titled "Hormonal Contraception and Vaginal Health". The purpose of this study is to help determine if the route by which women receive hormonal contraception causes different changes to occur in the lining of the vagina. The investigators plan to compare an oral route (taking birth control pills) with a vaginal route (using a vaginal ring).
What is the current status of trial NCT00612508?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2007-05. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00612508?
The interventions under investigation include: Desogen (ethinyl estradiol and desogestrel) (DRUG), NuvaRing (ethinyl estradiol and etonogestrel) (DRUG).
Who is sponsoring clinical trial NCT00612508?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00612508's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia